About Rhine Biogenics
Rhine Biogenics is a Healthcare company based in India founded in 2003. Rhine Biogenics is a pharmaceutical company specializing in dermatological and therapeutic products like creams, lotions, and serums. It operates on a B2B model. Its Indian entity Rhine Life Sciences Private Limited reported revenue of ₹5.14 Cr. Its focus areas include Pharmaceuticals, Dermatology and Topical Treatments. Its competitors include AmerisourceBergen, Entero Healthcare, Target Healthcare, CHEPLAPHARM and EBOS Group and 5 more; 5 of its 10 listed competitors have raised funding.
Company details
Rhine Biogenics operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, dermatology, and topical treatments. Rhine Biogenics is a pharmaceutical company specializing in dermatological and therapeutic products like creams, lotions, and serums. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters India
- SectorsHealthcare
- Email••••••••
- Website rhinebiogenics.com
- Legal Name Rhine Life Sciences Private Limited
- Date of Incorporation 08 Jun, 2006
- Jurisdiction Palakkad, Kerala, India
- Annual Revenue₹5.14 Cr
FY 2025 · 0% YoY
- Net Profit₹21.6 Lakh
FY 2025 · 4% margin
- EBITDA₹31.1 Lakh
FY 2025 · 6% margin
Associated legal entities of Rhine Biogenics
Rhine Biogenics is associated with 2 registered companies on The Company Check; the primary company is Rhine Life Sciences Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rhine Life Sciences Private Limited CIN U24232KL2006PTC019505 | Active | 08 Jun 2006 | Palakkad, Kerala | ₹5.1 Cr | – | 9 | View details |
| Rhine Biogenics Private Limited CIN U24232KL2003PTC016519 | Active | 08 Oct 2003 | Palghat, Kerala | ₹53.2 Cr | 47 | 10 | View details |
Board of directors of Rhine Life Sciences Private Limited (Rhine Biogenics)
Rhine Life Sciences Private Limited is the primary company behind Rhine Biogenics. The boards of the 2 registered companies of Rhine Biogenics currently have 14 directors; the longest-serving is Ajith Sukumaran Nair, appointed in 2003. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ajith Sukumaran Nair DIN 02461182 | Director | 17 Nov 2003 | 22 yrs 11 mo | Rhine Biogenics Private Limited |
| Jayakumar Narayanan Nair DIN 00078347 | Director | 17 Nov 2003 | 22 yrs 11 mo | Rhine Biogenics Private Limited |
| Kallungal Unni Jothish DIN 00362736 | Director | 17 Nov 2003 | 22 yrs 11 mo | Rhine Biogenics Private Limited |
| Madathiveetil Ramesh DIN 00362780 | Director | 17 Nov 2003 | 22 yrs 11 mo | Rhine Biogenics Private Limited |
| Vinod Menon Kumar DIN 00362755 | Director | 01 Aug 2004 | 22 yrs 2 mo | Rhine Biogenics Private Limited |
| Reji Joy DIN 00132817 | Director | 08 Jun 2006 | 20 yrs 4 mo | Rhine Life Sciences Private Limited, Rhine Biogenics Private Limited |
| Ajitkumar Warrior DIN 00078332 | Managing Director | 08 Jun 2006 | 20 yrs 4 mo | Rhine Life Sciences Private Limited, Rhine Biogenics Private Limited |
| Rajimon Kolakkal DIN 00132838 | Director | 08 Jun 2006 | 20 yrs 4 mo | Rhine Life Sciences Private Limited |
| Peter Jose Ansal Parriathcherry DIN 02491672 | Director | 08 Jun 2006 | 20 yrs 4 mo | Rhine Life Sciences Private Limited, Rhine Biogenics Private Limited |
| Porai Chacko Raphael DIN 00132833 | Director | 08 Jun 2006 | 20 yrs 4 mo | Rhine Life Sciences Private Limited |
| Pudugrammam Krishna Iyer Vaidyanathan DIN 00078261 | Director | 08 Jun 2006 | 20 yrs 4 mo | Rhine Life Sciences Private Limited, Rhine Biogenics Private Limited |
| Tirunilayi Krishnan Venugopal DIN 00078223 | Director | 08 Jun 2006 | 20 yrs 4 mo | Rhine Life Sciences Private Limited, Rhine Biogenics Private Limited |
| Manoj Mathew DIN 02825008 | Director | 01 Mar 2010 | 16 yrs 7 mo | Rhine Life Sciences Private Limited |
| Santhosh Bhaskaran DIN 07105715 | Director | 26 Jul 2015 | 11 yrs 2 mo | Rhine Life Sciences Private Limited |
Financials of Rhine Biogenics
Figures of Rhine Life Sciences Private Limited, the primary company behind Rhine Biogenics, for FY 2025. Revenue was ₹5.14 Cr (0% year on year). Net profit was ₹21.6 Lakh (4% margin). EBITDA was ₹31.1 Lakh (6% margin). Revenue has grown at a compounded annual rate of +7% over three years and +3% over five years.
- ₹5.14 CrRevenue · FY 2025 · 0% YoY
- ₹21.6 LakhNet profit · 4% margin
- ₹31.1 LakhEBITDA · 6% margin
- ₹1.6 LakhPaid-up capital
- +7%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Rhine Life Sciences Private Limited are on its company page.
Detailed financial statements for Rhine Biogenics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Rhine Biogenics
Rhine Biogenics has 10 listed competitors in our database, 5 of them funded. They include AmerisourceBergen, Entero Healthcare, Target Healthcare, CHEPLAPHARM and EBOS Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| target-healthcare.co.uk | 2012 | East Kilbride, United Kingdom | $26.15M | 45 | Distributor of pharmaceutical products | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| ebosgroup.com | 1922 | Docklands, Australia | – | – | Wholesaler & distributor of healthcare, medical, and pharmaceutical products | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| renee.com | 2021 | Los Angeles, United States | $8.2M | – | Diversified drugs are distributed by Renee in the United States. | |
| neuca.pl | 1990 | Torun, Poland | – | – | Wholesale distribution of pharmaceuticals is managed by NEUCA in Poland. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services | |
| kronansapotek.se | 2009 | Stockholm, Sweden | – | – | Pharmaceutical products are distributed by Kronans Apotek in Sweden. |
Detailed competitors of Rhine Biogenics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Rhine Biogenics
The website of Rhine Biogenics (rhinebiogenics.com) receives about 2K visits a month.
- Monthly visits2K
▼ 78% vs previous month
Top companies in Dermatology
10 companies that operate in the same segment as Rhine Biogenics (Dermatology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Developer of drugs for treating dermatology diseases | 1908 | Copenhagen, Denmark | USD 560.38 M | – | – | |
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | – | – | – | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608.25 M | – | 197 | |
Immunotherapeutic solutions for dermatological conditions are developed. | 2016 | Westlake Village, California, United States | USD 94.5 M | USD 376.07 M | 342 | |
Targeted small molecules are developed for oncology treatments. | 2010 | Singapore, Singapore | USD 100 M | – | – | |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 | |
Novel dermatologic therapies are developed for skin conditions. | 2012 | Malvern, Pennsylvania, United States | USD 82 M | USD 7.83 M | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rhine Biogenics
Rhine Biogenics was founded in 2003.
Rhine Biogenics is headquartered in India.
The primary company behind Rhine Biogenics, Rhine Life Sciences Private Limited, reported revenue of ₹5.14 Cr for FY 2025, down 0% year on year.
Rhine Biogenics operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, dermatology, and topical treatments. Rhine Biogenics is a pharmaceutical company specializing in dermatological and therapeutic products like creams, lotions, and serums. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Rhine Biogenics's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
Rhine Biogenics is associated with 2 legal entities: Rhine Life Sciences Private Limited, Rhine Biogenics Private Limited.
The legal entities of Rhine Biogenics currently have 14 directors, including Santhosh Bhaskaran, Reji Joy, Manoj Mathew and others.